1. 2022
  2. High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers

    del Moral-Sánchez, I., Russell, R. A., Schermer, E. E., Cottrell, C. A., Allen, J. D., Torrents de la Peña, A., LaBranche, C. C., Kumar, S., Crispin, M., Ward, A. B., Montefiori, D. C., Sattentau, Q. J., Sliepen, K. & Sanders, R. W., 1 Dec 2022, In: npj Vaccines. 7, 1, 27.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2021
  4. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern

    Brinkkemper, M., Brouwer, P. J. M., Maisonnasse, P., Grobben, M., Caniels, T. G., Poniman, M., Burger, J. A., Bontjer, I., Oomen, M., Bouhuijs, J. H., van der Linden, C. A., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., le Grand, R. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 146.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers (npj Vaccines, (2021), 6, 1, (103), 10.1038/s41541-021-00364-x)

    Sliepen, K., Schermer, E., Bontjer, I., Burger, J. A., Lévai, R. K. F., Mundsperger, P., Brouwer, P. J. M., Tolazzi, M., Farsang, A., Katinger, D., Moore, J. P., Scarlatti, G., Shattock, R. J., Sattentau, Q. J. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 134.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  6. Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers

    Sliepen, K., Schermer, E., Bontjer, I., Burger, J. A., Lévai, R. K. F., Mundsperger, P., Brouwer, P. J. M., Tolazzi, M., Farsang, A., Katinger, D., Moore, J. P., Scarlatti, G., Shattock, R. J., Sattentau, Q. J. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 103.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike

    Derking, R., Allen, J. D., Cottrell, C. A., Sliepen, K., Seabright, G. E., Lee, W-H., Aldon, Y., Rantalainen, K., Antanasijevic, A., Copps, J., Yasmeen, A., Cupo, A., Cruz Portillo, V. M., Poniman, M., Bol, N., van der Woude, P., de Taeye, S. W., van den Kerkhof, T. L. G. M., Klasse, P. J., Ozorowski, G. & 5 others, van Gils, M. J., Moore, J. P., Ward, A. B., Crispin, M. & Sanders, R. W., 6 Apr 2021, In: Cell reports. 35, 1, 108933.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S. G., Allen, J. D., Watanabe, Y., Giezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I. & 27 others, Burger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaître, J., Chapon, C., Fang, R. H. T., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B. L., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., le Grand, R. & Sanders, R. W., 4 Mar 2021, In: Cell. 184, 5, p. 1188-1200.e19 36 p., 365726.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins

    Kalemera, M. D., Capella-Pujol, J., Chumbe, A., Underwood, A., Bull, R. A., Schinkel, J., Sliepen, K. & Grove, J., 2021, In: Journal of general virology. 102, 1, 001512.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. 2020
  11. Optimized hepatitis C virus (HCV) e2 glycoproteins and their immunogenicity in combination with MVA-HCV

    Marín, M. Q., Sliepen, K., García-Arriaza, J., Koekkoek, S. M., Pérez, P., Sorzano, C. Ó. S., Gómez, C. E., Sanders, R. W. & Esteban, M., 1 Sep 2020, In: Vaccines. 8, 3, p. 1-25 25 p., 440.

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

    Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., Bentlage, A. E. H., van Haaren, M. M., Guerra, D., Burger, J. A., Schermer, E. E., Verheul, K. D., van der Velde, N., van der Kooi, A., van Schooten, J., van Breemen, M. J. & 13 others, Bijl, T. P. L., Sliepen, K., Aartse, A., Derking, R., Bontjer, I., Kootstra, N. A., Joost Wiersinga, W., Vidarsson, G., Haagmans, B. L., Ward, A. B., de Bree, G. J., Sanders, R. W. & van Gils, M. J., 7 Aug 2020, In: Science. 369, 6504, p. 643-650 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 Next

ID: 85314